Memantine is a noncompetitive N-methyl-d-aspartate receptor antagonist that is well tolerated. However, dementia patients presenting with confusion or worsening of visual hallucinations with memantine treatment have been reported. In this report, we describe an Alzheimer's disease patient presenting with severe auditory hallucination with memantine treatment.
|Journal||General Hospital Psychiatry|
|Publication status||Published - 2012|
- Alzheimer's disease (AD)
- Auditory hallucination
ASJC Scopus subject areas
- Psychiatry and Mental health